{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:25:14Z","timestamp":1761218714480,"version":"build-2065373602"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41390-025-03804-9","type":"journal-article","created":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T09:11:52Z","timestamp":1738141912000},"page":"1386-1394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased serum GM-CSF at diagnosis of biliary atresia is associated with improved biliary drainage"],"prefix":"10.1038","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3575-8386","authenticated-orcid":false,"given":"Sarah A.","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Harpavat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle D.","family":"Gromer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Andreev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"Loomes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaowapong","family":"Jarasvaraparn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasper","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Horslen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Teckman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela L.","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicky L.","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saul J.","family":"Karpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald J.","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estella M.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cara L.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Childhood Liver Disease Research Network (ChiLDReN)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,29]]},"reference":[{"key":"3804_CR1","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1002\/hep.29905","volume":"68","author":"JA Bezerra","year":"2018","unstructured":"Bezerra, J. A. et al. Biliary atresia: Clinical and research challenges for the twenty-first century. Hepatology 68, 1163\u20131173 (2018).","journal-title":"Hepatology"},{"key":"3804_CR2","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00383-017-4172-6","volume":"33","author":"A Kilgore","year":"2017","unstructured":"Kilgore, A. & Mack, C. L. Update on investigations pertaining to the pathogenesis of biliary atresia. Pediatr Surg Int 33, 1233\u20131241 (2017).","journal-title":"Pediatr Surg Int"},{"key":"3804_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3389\/fimmu.2020.00329","volume":"11","author":"A Ortiz-Perez","year":"2020","unstructured":"Ortiz-Perez, A. et al. Innate immunity and pathogenesis of biliary atresia. Front Immunol 11, 329 (2020).","journal-title":"Front Immunol"},{"key":"3804_CR4","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jpeds.2015.11.058","volume":"170","author":"BL Shneider","year":"2016","unstructured":"Shneider, B. L. et al. Total serum bilirubin within 3 months of hepatoportoenterostomy predicts short-term outcomes in biliary atresia. J Pediatr 170, 211\u2013217.e211-212 (2016).","journal-title":"J Pediatr"},{"key":"3804_CR5","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1542\/peds.2008-1949","volume":"123","author":"MO Serinet","year":"2009","unstructured":"Serinet, M. O. et al. Impact of age at kasai operation on its results in late childhood and adolescence: A rational basis for biliary atresia screening. Pediatrics 123, 1280\u20131286 (2009).","journal-title":"Pediatrics"},{"key":"3804_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1097\/SLA.0b013e3182300950","volume":"254","author":"R Superina","year":"2011","unstructured":"Superina, R. et al. The anatomic pattern of biliary atresia identified at time of kasai hepatoportoenterostomy and early postoperative clearance of jaundice are significant predictors of transplant-free survival. Ann Surg 254, 577\u2013585 (2011).","journal-title":"Ann Surg"},{"key":"3804_CR7","doi-asserted-by":"publisher","first-page":"150943","DOI":"10.1016\/j.sempedsurg.2020.150943","volume":"29","author":"M Hukkinen","year":"2020","unstructured":"Hukkinen, M., Pihlajoki, M. & Pakarinen, M. P. Predicting native liver injury and survival in biliary atresia. Semin Pediatr Surg 29, 150943 (2020).","journal-title":"Semin Pediatr Surg"},{"key":"3804_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1002\/hep.28851","volume":"65","author":"CS Lages","year":"2017","unstructured":"Lages, C. S. et al. The dendritic Cell-T Helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia. Hepatology 65, 174\u2013188 (2017).","journal-title":"Hepatology"},{"key":"3804_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1203\/01.PDR.0000130480.51066.FB","volume":"56","author":"CL Mack","year":"2004","unstructured":"Mack, C. L. et al. Biliary atresia is associated with Cd4+ Th1 cell-mediated portal tract inflammation. Pediatr Res 56, 79\u201387 (2004).","journal-title":"Pediatr Res"},{"key":"3804_CR10","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1097\/PAS.0000000000000755","volume":"40","author":"P Russo","year":"2016","unstructured":"Russo, P. et al. Key histopathologic features of liver biopsies that distinguish biliary atresia from other causes of infantile cholestasis and their correlation with outcome: A multicenter study. Am J Surg Pathol 40, 1601\u20131615 (2016).","journal-title":"Am J Surg Pathol"},{"key":"3804_CR11","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/j.jpedsurg.2015.02.005","volume":"50","author":"R Hill","year":"2015","unstructured":"Hill, R. et al. Th-17 cells infiltrate the liver in human biliary atresia and are related to surgical outcome. J Pediatr Surg 50, 1297\u20131303 (2015).","journal-title":"J Pediatr Surg"},{"key":"3804_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/hep4.1332","volume":"3","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Correlation of immune markers with outcomes in biliary atresia following intravenous immunoglobulin therapy. Hepatol Commun 3, 685\u2013696 (2019).","journal-title":"Hepatol Commun"},{"key":"3804_CR13","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11894-017-0555-z","volume":"19","author":"RN Lopez","year":"2017","unstructured":"Lopez, R. N., Ooi, C. Y. & Krishnan, U. Early and peri-operative prognostic indicators in infants undergoing hepatic portoenterostomy for biliary atresia: A review. Curr Gastroenterol Rep 19, 16 (2017).","journal-title":"Curr Gastroenterol Rep"},{"key":"3804_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jpeds.2018.12.006","volume":"208","author":"JF Wu","year":"2019","unstructured":"Wu, J. F. et al. Quantification of serum matrix metallopeptide 7 levels may assist in the diagnosis and predict the outcome for patients with biliary atresia. J Pediatr 208, 30\u201337.e31 (2019).","journal-title":"J Pediatr"},{"key":"3804_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/S0022-3468(97)90714-4","volume":"32","author":"H Kobayashi","year":"1997","unstructured":"Kobayashi, H., Puri, P., O\u2019Briain, D. S., Surana, R. & Miyano, T. Hepatic Overexpression of Mhc Class Ii Antigens and Macrophage-Associated Antigens (Cd68) in patients with biliary atresia of poor prognosis. J Pediatr Surg 32, 590\u2013593 (1997).","journal-title":"J Pediatr Surg"},{"key":"3804_CR16","doi-asserted-by":"publisher","first-page":"e0267363","DOI":"10.1371\/journal.pone.0267363","volume":"17","author":"W Udomsinprasert","year":"2022","unstructured":"Udomsinprasert, W., Ungsudechachai, T., Vejchapipat, P., Poovorawan, Y. & Honsawek, S. Systemic cytokine profiles in biliary atresia. PLoS ONE 17, e0267363 (2022).","journal-title":"PLoS ONE"},{"key":"3804_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3389\/fimmu.2014.00491","volume":"5","author":"G Arango Duque","year":"2014","unstructured":"Arango Duque, G. & Descoteaux, A. Macrophage cytokines: Involvement in immunity and infectious diseases. Front Immunol 5, 491 (2014).","journal-title":"Front Immunol"},{"key":"3804_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","volume":"18","author":"Y Wen","year":"2021","unstructured":"Wen, Y., Lambrecht, J., Ju, C. & Tacke, F. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Cell Mol Immunol 18, 45\u201356 (2021).","journal-title":"Cell Mol Immunol"},{"key":"3804_CR19","doi-asserted-by":"publisher","first-page":"e0244743","DOI":"10.1371\/journal.pone.0244743","volume":"16","author":"SA Taylor","year":"2021","unstructured":"Taylor, S. A. et al. Transcriptional profiling of pediatric cholestatic livers identifies three distinct macrophage populations. PLoS ONE 16, e0244743 (2021).","journal-title":"PLoS ONE"},{"key":"3804_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","volume":"178","author":"DA Jaitin","year":"2019","unstructured":"Jaitin, D. A. et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686\u2013698.e614 (2019).","journal-title":"Cell"},{"key":"3804_CR21","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1002\/hep.26512","volume":"58","author":"KB Schwarz","year":"2013","unstructured":"Schwarz, K. B. et al. Extrahepatic anomalies in infants with biliary atresia: results of a large prospective North American Multicenter Study. Hepatology 58, 1724\u20131731 (2013).","journal-title":"Hepatology"},{"key":"3804_CR22","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cld.2022.03.001","volume":"26","author":"S Antala","year":"2022","unstructured":"Antala, S. & Taylor, S. A. Biliary atresia in children: Update on disease mechanism, therapies, and patient outcomes. Clin Liver Dis 26, 341\u2013354 (2022).","journal-title":"Clin Liver Dis"},{"key":"3804_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0022-3468(96)90333-4","volume":"31","author":"TF Tracy Jr.","year":"1996","unstructured":"Tracy, T. F. Jr., Dillon, P., Fox, E. S., Minnick, K. & Vogler, C. The inflammatory response in pediatric biliary disease: Macrophage phenotype and distribution. J Pediatr Surg 31, 121\u2013125 (1996).","journal-title":"J Pediatr Surg"},{"key":"3804_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1053\/jpsu.2001.24730","volume":"36","author":"M Davenport","year":"2001","unstructured":"Davenport, M. et al. Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia. J Pediatr Surg 36, 1017\u20131025 (2001).","journal-title":"J Pediatr Surg"},{"key":"3804_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2024.1338131","volume":"12","author":"K Nagayabu","year":"2024","unstructured":"Nagayabu, K. et al. The clinical impact of macrophage polarity after kasai portoenterostomy in biliary atresia. Front Pediatr 12, 1338131 (2024).","journal-title":"Front Pediatr"},{"key":"3804_CR26","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.cell.2020.10.048","volume":"183","author":"J Wang","year":"2020","unstructured":"Wang, J. et al. Liver immune profiling reveals pathogenesis and therapeutics for biliary atresia. Cell 183, 1867\u20131883.e1826 (2020).","journal-title":"Cell"},{"key":"3804_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1070","volume":"12","author":"C Ye","year":"2022","unstructured":"Ye, C. et al. Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia. Clin Transl Med 12, e1070 (2022).","journal-title":"Clin Transl Med"},{"key":"3804_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100908","volume":"5","author":"R Ye","year":"2023","unstructured":"Ye, R. et al. Single cell RNA-sequencing analysis reveals that n-acetylcysteine partially reverses hepatic immune dysfunction in biliary atresia. JHEP Rep 5, 100908 (2023).","journal-title":"JHEP Rep"},{"key":"3804_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2023.104974","volume":"287","author":"AK Ram","year":"2023","unstructured":"Ram, A. K. et al. Polymeric immunoglobulin receptor and galectin-3-binding protein are raised in biliary atresia: reveals a proteomic-based study. J Proteom 287, 104974 (2023).","journal-title":"J Proteom"},{"key":"3804_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812431","volume":"13","author":"S She","year":"2022","unstructured":"She, S. et al. Functional roles of chemokine receptor ccr2 and its ligands in liver disease. Front Immunol 13, 812431 (2022).","journal-title":"Front Immunol"},{"key":"3804_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. Ccr2 promotes hepatic fibrosis in mice. Hepatology 50, 185\u2013197 (2009).","journal-title":"Hepatology"},{"key":"3804_CR32","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.90780","volume":"2","author":"SY Cai","year":"2017","unstructured":"Cai, S. Y. et al. Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. JCI Insight 2, e90780 (2017).","journal-title":"JCI Insight"},{"key":"3804_CR33","doi-asserted-by":"publisher","first-page":"e166954","DOI":"10.1172\/JCI166954","volume":"133","author":"D Feng","year":"2023","unstructured":"Feng, D. et al. Monocyte-derived macrophages orchestrate multiple cell-type interactions to repair necrotic liver lesions in disease models. J Clin Invest 133, e166954 (2023).","journal-title":"J Clin Invest"},{"key":"3804_CR34","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1111\/imr.12462","volume":"274","author":"M Martin","year":"2016","unstructured":"Martin, M. & Blom, A. M. Complement in removal of the dead - balancing inflammation. Immunol Rev 274, 218\u2013232 (2016).","journal-title":"Immunol Rev"},{"key":"3804_CR35","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1002\/hep4.2097","volume":"6","author":"A Eguchi","year":"2022","unstructured":"Eguchi, A. et al. Complement complex 1 subunit q-mediated hepatic stellate cell activation with connective tissue growth factor elevation is a prognostic factor for survival in rat and human chronic liver diseases. Hepatol Commun 6, 3515\u20133527 (2022).","journal-title":"Hepatol Commun"},{"key":"3804_CR36","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.jcmgh.2023.03.002","volume":"15","author":"J Vonderlin","year":"2023","unstructured":"Vonderlin, J., Chavakis, T., Sieweke, M. & Tacke, F. The multifaceted roles of macrophages in NAFLD pathogenesis. Cell Mol Gastroenterol Hepatol 15, 1311\u20131324 (2023).","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"3804_CR37","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.3390\/jcm10091978","volume":"10","author":"O Madadi-Sanjani","year":"2021","unstructured":"Madadi-Sanjani, O. et al. Growth factors assessed during kasai procedure in liver and serum are not predictive for the postoperative liver deterioration in infants with biliary atresia. J Clin Med 10, 1978 (2021).","journal-title":"J Clin Med"},{"key":"3804_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1007\/s00383-022-05115-0","volume":"38","author":"HPA Nguyen","year":"2022","unstructured":"Nguyen, H. P. A. et al. Study protocol of phase 2 open-label multicenter randomized controlled trial for granulocyte-colony stimulating factor (Gcsf) in post-kasai type 3 biliary atresia. Pediatr Surg Int 38, 1019\u20131030 (2022).","journal-title":"Pediatr Surg Int"},{"key":"3804_CR39","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/MPG.0000000000002450","volume":"69","author":"KR Mysore","year":"2019","unstructured":"Mysore, K. R., Shneider, B. L. & Harpavat, S. Biliary atresia as a disease starting in utero: implications for treatment, diagnosis, and pathogenesis. J Pediatr Gastroenterol Nutr 69, 396\u2013403 (2019).","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3804_CR40","doi-asserted-by":"publisher","first-page":"e1428","DOI":"10.1542\/peds.2011-1869","volume":"128","author":"S Harpavat","year":"2011","unstructured":"Harpavat, S., Finegold, M. J. & Karpen, S. J. Patients with biliary atresia have elevated direct\/conjugated bilirubin levels shortly after birth. Pediatrics 128, e1428\u2013e1433 (2011).","journal-title":"Pediatrics"}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03804-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03804-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:49:23Z","timestamp":1761205763000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-025-03804-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,29]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["3804"],"URL":"https:\/\/doi.org\/10.1038\/s41390-025-03804-9","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"type":"print","value":"0031-3998"},{"type":"electronic","value":"1530-0447"}],"subject":[],"published":{"date-parts":[[2025,1,29]]},"assertion":[{"value":"13 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SAT serves as a consultant for Ipsen and Mirum Pharma. SH serves on the Data Safety Monitoring Board coordinated by Syneos Health for a therapeutic drug trial for biliary atresia. KML serves as a consultant for Ipsen and Mirum Pharma. PV serves on the Speaker\u2019s Bureau for Mirum and is a consultant for Grifols. SJK serves as a consultant for Ipsen, Hemoshear, Intercept, Mirum, and Vertex. RJS serves as consultant for Ipsen and Mirum Pharma. All remaining coauthors declare no conflicts of interest for this manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Written informed consent was obtained for all participants. Institutional review board approval was obtained for the study and conformed to the ethical guidelines of the 1975 Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent statement"}}]}}